Salmon calcitonin appears ineffective in the management of knee OA treatment in 2 RCTs
Salmon calcitonin appears ineffective in the management of knee OA treatment in 2 RCTs
Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials
Osteoarthritis Cartilage. 2015 Apr;23(4):532-43.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Two randomized control trials, with a combined 2206 patients, studied the effects of salmon calcitonin (sCT) in patients with symptomatic knee osteoarthritis. Changes in joint space width, pain, function, and safety were evaluated over a 24 month period after treatment began. The results of these trials indicated that salmon calcitonin did not have an effect on joint space width in comparison to p...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.